But it will be up to doctors whether to use the combo in Darzalex-exposed patients.
ApexOnco Front Page
Recent articles
Persevera is a bust, but Roche hasn’t given up on the front line.
Studies presented at ASH show this to be true only up to a point.
Linker-MM4 data raise more questions about sequencing of therapies for multiple myeloma.
Pfizer reveals the discontinuation of PF-08046044.
The company might have blown Enliven out of the water.
Tecvayli plus Darzalex could challenge Carvykti in the push for a functional cure.
The company will try to get the Komzifti QTc prolongation warning removed.
